News
Vinay Prasad, a top regulator at the US Food and Drug Administration, left the agency after a short-lived tenure that ended ...
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
The immediate ebullient reaction to Vinay Prasad’s ouster is understandable, and may ultimately be the correct one, Adam ...
Such appeasement efforts proved insufficient to protect him from rival forces in the Republican Party, if not also in the ...
Vinay Prasad, who came under fire from patient advocacy groups and Laura Loomer, is gone after less than three months on the ...
Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results